Suresh Thangudu

Dr. Suresh Thangudu

Center for General Education, Chang Gung University, Taoyuan City, Taiwan
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
STSuresh Thangudu
Suresh Thangudu
CSChia-Hao Su
Chia-Hao Su
Nanomaterial-mediated cancer therapeutics is a fast developing field and has been utilized in potential clinical applications. However, most effective therapies, such as photodynamic therapy (PDT) and radio therapy (RT), are strongly oxygen-dependent, which hinders their practical applications. Later on, several strategies were developed to overcome tumor hypoxia, such as oxygen carrier nanomaterials and oxygen generated nanomaterials. Among these, oxygen species generation on nanozymes, especially catalase (CAT) mimetic nanozymes, convert endogenous hydrogen peroxide (H2O2) to oxygen (O2) and peroxidase (POD) mimetic nanozymes converts endogenous H2O2 to water (H2O) and reactive oxygen species (ROS) in a hypoxic tumor microenvironment is a fascinating approach. The present review provides a detailed examination of past, present and future perspectives of POD mimetic nanozymes for effective oxygen-dependent cancer phototherapeutics.

20 December 2020 in Polymers
Verified
Journal Article
Open access
PDF file
STSuresh Thangudu
Suresh Thangudu
FCFong-Yu Cheng
Fong-Yu Cheng
CSChia-Hao Su
Chia-Hao Su
Noninvasive treatments to treat the brain-related disorders have been paying more significant attention and it is an emerging topic. However, overcoming the blood brain barrier (BBB) is a key obstacle to most of the therapeutic drugs to enter into the brain tissue, which significantly results in lower accumulation of therapeutic drugs in the brain. Thus, administering the large quantity/doses of drugs raises more concerns of adverse side effects. Nanoparticle (NP)-mediated drug delivery systems are seen as potential means of enhancing drug transport across the BBB and to targeted brain tissue. These systems offer more accumulation of therapeutic drugs at the tumor site and prolong circulation time in the blood. In this review, we summarize the current knowledge and advancements on various nanoplatforms (NF) and discusses the use of nanoparticles for successful cross of BBB to treat the brain-related disorders such as brain tumors, Alzheimer’s disease, Parkinson’s disease, and stroke.

5 August 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
LWLiu-Chun Wang
Liu-Chun Wang
PCPei-Yu Chiou
Pei-Yu Chiou
YHYa-Ping Hsu
Ya-Ping Hsu
CLChin-Lai Lee
Chin-Lai Lee
CHChih-Hsuan Hung
Chih-Hsuan Hung
Chen-Sheng YehChen-Sheng Yeh
Chen-Sheng Yeh
Chemodynamic therapy (CDT) uses the Fenton or Fenton-like reaction to yield toxic ‧OH following H2O2 → ‧OH for tumoral therapy. Unfortunately, H2O2 is often taken from the limited endogenous supply of H2O2 in cancer cells. A water oxidation CoFe Prussian blue (CFPB) nanoframes is presented to provide sustained, external energy-free self-supply of ‧OH from H2O to process CDT and/or photothermal therapy (PTT). Unexpectedly, the as-prepared CFPB nanocubes with no near-infrared (NIR) absorption is transformed into CFPB nanoframes with NIR absorption due to the increased Fe3+-N ≡ C-Fe2+ composition through the proposed proton-induced metal replacement reactions. Surprisingly, both the CFPB nanocubes and nanoframes provide for the self-supply of O2, H2O2, and ‧OH from H2O, with the nanoframe outperforming in the production of ‧OH. Simulation analysis indicates separated active sites in catalyzation of water oxidation, oxygen reduction, and Fenton-like reactions from CFPB. The liposome-covered CFPB nanoframes prepared for controllable water-driven CDT for male tumoral mice treatments.

11 August 2022 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
YCYing‐Chi Chen
Ying‐Chi Chen
YLYu‐Ju Liu
Yu‐Ju Liu
CLChin‐Lai Lee
Chin‐Lai Lee
KPKhang-Yen Pham
Khang-Yen Pham
DMDivinah Manoharan
Divinah Manoharan
Chen-Sheng YehChen-Sheng Yeh
Chen-Sheng Yeh

13 August 2020 in Bioengineering
Verified
Journal Article
Open access
PDF file
Chiranjeevi KorupalliChiranjeevi Korupalli
Chiranjeevi Korupalli
PKPoliraju Kalluru
Poliraju Kalluru
KNKarthik Nuthalapati
Karthik Nuthalapati
NKNaresh Kuthala
Naresh Kuthala
STSuresh Thangudu
Suresh Thangudu
Raviraj VankayalaRaviraj Vankayala
Raviraj Vankayala
Conventional treatments fail to completely eradicate tumor or bacterial infections due to their inherent shortcomings. In recent years, photothermal therapy (PTT) has emerged as an attractive treatment modality that relies on the absorption of photothermal agents (PTAs) at a specific wavelength, thereby transforming the excitation light energy into heat. The advantages of PTT are its high efficacy, specificity, and minimal damage to normal tissues. To this end, various inorganic nanomaterials such as gold nanostructures, carbon nanostructures, and transition metal dichalcogenides have been extensively explored for PTT applications. Subsequently, the focus has shifted to the development of polymeric PTAs, owing to their unique properties such as biodegradability, biocompatibility, non-immunogenicity, and low toxicity when compared to inorganic PTAs. Among various organic PTAs, polyaniline (PANI) is one of the best-known and earliest-reported organic PTAs. Hence, in this review, we cover the recent advances and progress of PANI-based biomaterials for PTT application in tumors and bacterial infections. The future prospects in this exciting area are also addressed.

12 May 2020 in Nanoscale
Verified
Journal Article
Closed access
PDF file
STSuresh Thangudu
Suresh Thangudu
SKSagar Sunil Kulkarni
Sagar Sunil Kulkarni
Raviraj VankayalaRaviraj Vankayala
Raviraj Vankayala
CCChi-Shiun Chiang
Chi-Shiun Chiang
KHKuo Chu Hwang
Kuo Chu Hwang
Due to the rapid growth of drug-resistant bacterial infections, there is an urgent need to develop innovative antimicrobial strategies to conquer the bacterial antibiotic resistance problems. Although a few nanomaterial-based antimicrobial strategies have been developed, the sensitized formation of cytotoxic reactive chlorine species (RCS), including chlorine gas and chlorine free radicals, by photo-activatable plasmonic nanoparticles for evading drug-resistant bacterial infections has not yet been reported. To address this challenge, herein, we report the synthesis of an unprecedented plasmonic core–shell Ag@AgCl nanocrystal through an in situ oxidation route for the photo-induced generation of highly cytotoxic RCS. We present the detailed in vitro and in vivo investigations of visible light activated Ag@AgCl nanostructure-mediated evasion of drug-resistant bacteria. In particular, the in vivo results demonstrate the complete reepithelialization of the methicillin-resistant Staphylococcus aureus (MRSA) infected wounds on skin upon phototherapeutic treatment mediated Ag@AgCl NCs. To the best of our knowledge, this is the first unique example of using Ag@AgCl NCs as an external nanomedicine for photo-induced generation of RCS to mediate effective killing of both Gram-positive and Gram-negative drug resistance bacteria and healing of the subcutaneous abscesses in an in vivo mouse model.